Virax Biolabs shares are trading higher after the company announced it extended its existing exclusive distribution agreement with Cosmos Health to market Mpox in real time through its PCR detection kits.
Portfolio Pulse from Benzinga Newsdesk
Virax Biolabs shares rose following the extension of its exclusive distribution agreement with Cosmos Health to market Mpox using its PCR detection kits.
September 16, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Virax Biolabs' stock price increased after announcing the extension of its distribution agreement with Cosmos Health for marketing Mpox through PCR detection kits.
The extension of the distribution agreement with Cosmos Health is a positive development for Virax Biolabs, as it enhances the company's market reach for its Mpox PCR detection kits. This news likely contributed to the rise in VRAX shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100